Works matching AU Quaglino, P.
Results: 107
Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome.
- Published in:
- Clinical & Experimental Immunology, 2014, v. 178, n. 1, p. 48, doi. 10.1111/cei.12394
- By:
- Publication type:
- Article
Dermatomyositis in 132 Patients with Different Clinical Subtypes: Cutaneous Signs, Constitutional Symptoms and Circulating Antibodies.
- Published in:
- Acta Dermato-Venereologica, 2002, v. 82, n. 1, p. 48, doi. 10.1080/000155502753600894
- By:
- Publication type:
- Article
Fluorescence-advanced videodermatoscopy: a new method for in vivo skin evaluation.
- Published in:
- British Journal of Dermatology, 2017, v. 177, n. 5, p. e209, doi. 10.1111/bjd.15594
- By:
- Publication type:
- Article
Dermoscopic diagnosis of amelanotic/hypomelanotic melanoma.
- Published in:
- British Journal of Dermatology, 2017, v. 177, n. 2, p. 538, doi. 10.1111/bjd.15093
- By:
- Publication type:
- Article
Arrhythmias in a patient with metastatic melanoma treated with targeted therapy and implantable cardioverter defibrillator.
- Published in:
- British Journal of Dermatology, 2017, v. 177, n. 2, p. 584, doi. 10.1111/bjd.15447
- By:
- Publication type:
- Article
Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB- IVA mycosis fungoides/Sézary syndrome.
- Published in:
- British Journal of Dermatology, 2016, v. 175, n. 1, p. 80, doi. 10.1111/bjd.14427
- By:
- Publication type:
- Article
The Treg/Th17 cell ratio is reduced in the skin lesions of patients with pyoderma gangrenosum.
- Published in:
- British Journal of Dermatology, 2015, v. 173, n. 1, p. 275, doi. 10.1111/bjd.13670
- By:
- Publication type:
- Article
Pigmented nodular melanoma: the predictive value of dermoscopic features using multivariate analysis.
- Published in:
- British Journal of Dermatology, 2015, v. 173, n. 1, p. 106, doi. 10.1111/bjd.13861
- By:
- Publication type:
- Article
Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases
- Published in:
- British Journal of Dermatology, 2015, v. 173, n. 1, p. 93, doi. 10.1111/bjd.13832
- By:
- Publication type:
- Article
Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?
- Published in:
- British Journal of Dermatology, 2014, v. 170, n. 6, p. 1226, doi. 10.1111/bjd.12909
- By:
- Publication type:
- Article
A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides.
- Published in:
- British Journal of Dermatology, 2014, v. 170, n. 6, p. 1266, doi. 10.1111/bjd.12717
- By:
- Publication type:
- Article
Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients.
- Published in:
- British Journal of Dermatology, 2013, v. 169, n. 6, p. 1240, doi. 10.1111/bjd.12586
- By:
- Publication type:
- Article
Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.
- Published in:
- British Journal of Dermatology, 2010, v. 162, n. 5, p. 1056, doi. 10.1111/j.1365-2133.2010.09633.x
- By:
- Publication type:
- Article
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role.
- Published in:
- British Journal of Dermatology, 2008, v. 159, n. 5, p. 1131, doi. 10.1111/j.1365-2133.2008.08811.x
- By:
- Publication type:
- Article
Expression of matrix metalloproteinases 2, 9 and 11 in erythema multiforme: immunohistochemical comparison with Stevens–Johnson syndrome/toxic epidermal necrolysis.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Serum interleukin-13 levels are increased in patients with Stevens–Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens–Johnson syndrome/toxic epidermal necrolysis.
- Published in:
- British Journal of Dermatology, 2006, v. 155, n. 4, p. 722, doi. 10.1111/j.1365-2133.2006.07398.x
- By:
- Publication type:
- Article
Elevated circulating CD40 ligand in patients with erythema multiforme and Stevens–Johnson syndrome/toxic epidermal necrolysis spectrum.
- Published in:
- 2006
- By:
- Publication type:
- Letter
The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens–Johnson syndrome/toxic epidermal necrolysis spectrum.
- Published in:
- British Journal of Dermatology, 2006, v. 154, n. 2, p. 319, doi. 10.1111/j.1365-2133.2005.07023.x
- By:
- Publication type:
- Article
T-cell receptor γ gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings
- Published in:
- British Journal of Dermatology, 2005, v. 153, n. 3, p. 565, doi. 10.1111/j.1365-2133.2005.06649.x
- By:
- Publication type:
- Article
Therapeutics Treatment of advanced mycosis fungoides /Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
- Published in:
- British Journal of Dermatology, 2004, v. 150, n. 2, p. 327, doi. 10.1111/j.1365-2133.2004.05712.x
- By:
- Publication type:
- Article
The relevance of the CD4+ CD26– subset in the identification of circulating Sézary cells.
- Published in:
- British Journal of Dermatology, 2001, v. 144, n. 1, p. 125, doi. 10.1046/j.1365-2133.2001.04014.x
- By:
- Publication type:
- Article
CD56 -- positive cutaneous lymphoma: a poorly recognized entity in the spectrum of primary cutaneous disease.
- Published in:
- British Journal of Dermatology, 1997, v. 137, n. 6, p. 966
- By:
- Publication type:
- Article
Ipilimumab retreatment in patients with pretreated advanced melanoma: the expanded access programme in Italy.
- Published in:
- British Journal of Cancer, 2014, v. 110, n. 7, p. 1721, doi. 10.1038/bjc.2014.126
- By:
- Publication type:
- Article
In vitro effects of cholesteryl butyrate solid lipid nanospheres as a butyric acid pro-drug on melanoma cells: Evaluation of antiproliferative activity and apoptosis induction.
- Published in:
- Clinical & Experimental Metastasis, 2000, v. 18, n. 8, p. 663, doi. 10.1023/A:1013186331662
- By:
- Publication type:
- Article
FINAL DATA FROM THE PHASE 3 ALCANZA STUDY: BRENTUXIMAB VEDOTIN (BV) VS PHYSICIAN'S CHOICE (PC) IN PATIENTS (PTS) WITH CD30‐POSITIVE (CD30+) CUTANEOUS T‐CELL LYMPHOMA (CTCL).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 286, doi. 10.1002/hon.96_2630
- By:
- Publication type:
- Article
FINAL DATA FROM THE PHASE 3 ALCANZA STUDY: BRENTUXIMAB VEDOTIN (BV) VS PHYSICIAN'S CHOICE (PC) IN PATIENTS (PTS) WITH CD30‐POSITIVE (CD30+) CUTANEOUS T‐CELL LYMPHOMA (CTCL).
- Published in:
- Hematological Oncology, 2019, v. 37, p. 286, doi. 10.1002/hon.96_2630
- By:
- Publication type:
- Article
RESPONSE BY STAGE IN CD30-POSITIVE (CD30+) CUTANEOUS T CELL LYMPHOMA (CTCL) PATIENTS RECEIVING BRENTUXIMAB VEDOTIN (BV) VS PHYSICIAN'S CHOICE (PC) IN THE PHASE 3 ALCANZA STUDY.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 245, doi. 10.1002/hon.2438_109
- By:
- Publication type:
- Article
BRENTUXIMAB VEDOTIN VS PHYSICIAN'S CHOICE IN CTCL PATIENTS FROM THE PHASE 3 ALCANZA STUDY: ANALYSIS OF OUTCOMES BY CD30 EXPRESSION.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 77, doi. 10.1002/hon.2437_65
- By:
- Publication type:
- Article
PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN PATIENTS WITH CUTANEOUS T CELL LYMPHOMA: RESULTS FROM THE PHASE 3 ALCANZA STUDY.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 247, doi. 10.1002/hon.2438_110
- By:
- Publication type:
- Article
Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study.
- Published in:
- Expert Opinion on Biological Therapy, 2023, v. 23, n. 4, p. 365, doi. 10.1080/14712598.2023.2193288
- By:
- Publication type:
- Article
Disseminated Kaposi's sarcoma associated with idiopathic CD4+ lymphocytopenia and low dose steroid therapy.
- Published in:
- Clinical & Experimental Dermatology, 2005, v. 30, n. 4, p. 395, doi. 10.1111/j.1365-2230.2005.01795.x
- By:
- Publication type:
- Article
CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients.
- Published in:
- Journal of Cutaneous Pathology, 2001, v. 28, n. 7, p. 356, doi. 10.1034/j.1600-0560.2001.280704.x
- By:
- Publication type:
- Article
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients.
- Published in:
- Archives of Dermatological Research, 2012, v. 304, n. 8, p. 639, doi. 10.1007/s00403-012-1213-9
- By:
- Publication type:
- Article
Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases.
- Published in:
- British Journal of Dermatology, 1996, v. 134, n. 6, p. 1052, doi. 10.1111/j.1365-2133.1996.tb07941.x
- By:
- Publication type:
- Article
Tyrosinase expression in the peripheral blood of stage III melanoma patients is associated with a poor prognosis: a clinical follow-up study of 110 patients.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Impact of comorbidities in elderly and frail patients and response to biological therapy in psoriasis.
- Published in:
- Experimental Dermatology, 2023, v. 32, n. 7, p. 1162, doi. 10.1111/exd.14822
- By:
- Publication type:
- Article
Multicentric EORTC retrospective study shows efficacy of brentuximab vedotin in patients who have mycosis fungoides and Sézary syndrome with variable CD30 positivity*.
- Published in:
- British Journal of Dermatology, 2021, v. 185, n. 5, p. 1035, doi. 10.1111/bjd.20588
- By:
- Publication type:
- Article
Treatment of early‐stage mycosis fungoides: results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study.
- Published in:
- British Journal of Dermatology, 2021, v. 184, n. 4, p. 722, doi. 10.1111/bjd.19252
- By:
- Publication type:
- Article
Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study*.
- Published in:
- British Journal of Dermatology, 2021, v. 184, n. 3, p. 524, doi. 10.1111/bjd.19303
- By:
- Publication type:
- Article
The prognostic impact of the extent of ulceration in patients with clinical stage I–II melanoma: a multicentre study of the Italian Melanoma Intergroup (IMI).
- Published in:
- British Journal of Dermatology, 2021, v. 184, n. 2, p. 281, doi. 10.1111/bjd.19120
- By:
- Publication type:
- Article
The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients.
- Published in:
- British Journal of Dermatology, 2019, v. 181, n. 2, p. 350, doi. 10.1111/bjd.17258
- By:
- Publication type:
- Article
Ethnicity in mycosis fungoides: white patients present at an older age and with more advanced disease.
- Published in:
- British Journal of Dermatology, 2019, v. 180, n. 5, p. 1264, doi. 10.1111/bjd.17602
- By:
- Publication type:
- Article
Prognostic role of histological regression in primary cutaneous melanoma: a systematic review and meta‐analysis.
- Published in:
- British Journal of Dermatology, 2018, v. 178, n. 2, p. 357, doi. 10.1111/bjd.15552
- By:
- Publication type:
- Article
Drug survival, effectiveness and safety of ixekizumab for moderate‐to‐severe psoriasis up to 5 years.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 3, p. 568, doi. 10.1111/jdv.19682
- By:
- Publication type:
- Article
'Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients'—response to Yu et al.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 2, p. e175, doi. 10.1111/jdv.19517
- By:
- Publication type:
- Article
Collaborative efforts in studying Mediterranean melanoma families: A step towards precision medicine.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 12, p. 2405, doi. 10.1111/jdv.19529
- By:
- Publication type:
- Article
Topical ruxolitinib: A new treatment for vitiligo.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 11, p. 2222, doi. 10.1111/jdv.19162
- By:
- Publication type:
- Article
Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 9, p. 1848, doi. 10.1111/jdv.19135
- By:
- Publication type:
- Article
Primary cutaneous lymphoma patients seen at a referral dermatological centre in 1 year: A single‐centre observational retrospective cohort study of the diagnoses and staging, comorbidities and associated symptoms, treatment performed and clinical course
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2022, v. 36, n. 12, p. 2388, doi. 10.1111/jdv.18469
- By:
- Publication type:
- Article